Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Mylan introduces MyHep tablets in India to treat chronic hepatitis C By PBR Staff Writer
Mylan Pharmaceuticals has introduced generic version of Sofosbuvir 400mg tablets in India under the brand name MyHep.
Production & Manufacturing > Manufacturing > News
Concordia acquires Covis Pharma commercial assets for $1.2bn By PBR Staff Writer
Concordia Healthcare has completed the acquisition of 18 branded and authorized generic products from Covis Pharma and Covis Injectables (collectively 'Covis') for $1.2bn.
Production & Manufacturing > Manufacturing > News Elite introduces generic hydroxyzine tablets By PBR Staff Writer
Elite Pharmaceuticals has launched the generic Hydroxyzine HCI 10mg, 25mg and 50mg tablets through Epic Pharma, a US-based pharmaceutical company.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Technology Platform
Including: Effervescent tables, effervescent granular in sachet, granular in sachets, orally disintegrating tablets, extended release tablets and soft gelatin capsules.
Production & Manufacturing > Manufacturing > Products
Concordia acquires Covis Pharma commercial assets for $1.2bn
By PBR Staff Writer
Concordia Healthcare has completed the acquisition of 18 branded and authorized generic products from Covis Pharma and Covis Injectables (collectively 'Covis') for $1.2bn.
Production & Manufacturing > Manufacturing > News
Elite introduces generic hydroxyzine tablets
By PBR Staff Writer
Elite Pharmaceuticals has launched the generic Hydroxyzine HCI 10mg, 25mg and 50mg tablets through Epic Pharma, a US-based pharmaceutical company.
Production & Manufacturing > Manufacturing > News
Teva offers to acquire Mylan for $40.1bn
By PBR Staff Writer
Israel-based Teva Pharmaceutical Industries has submitted a bid to acquire generic drug-maker Mylan in a deal that could be worth $40.1bn
Production & Manufacturing > Manufacturing > News
A High Quality Formulation Development and Manufacturing Company
| By Alpex Pharma
Our predominant focus is the development of solid dosage forms to deliver drugs directly into the oral cavity in order to potentially improve both the bioavailablity of the drug as well as patient compliance and convenience to it. Alpex Pharma has 28 years of cGMP manufacturing experience and formulation development.
Production & Manufacturing > Manufacturing > White Papers
Daiichi Sankyo agrees to sell up to $3.6bn stake in Sun Pharma
By PBR Staff Writer
Japanese drugmaker Daiichi Sankyo is selling a part or entire 9% holding worth up to $3.6bn in Indian drugmaker Sun Pharmaceutical Industries.
Production & Manufacturing > Manufacturing > News
Powder Manufacturing
According to Labo Smeets, powders deserve full focus. They can be bulky and hard to handle, but with the right experience and equipment the powder market still holds a lot of promise. We produce several hundreds of millions of sachets per year. Our production runs are small to medium size. Other packaging forms are dispensers for products such as Talcum, or 25 kg bags for voluminous products.
Production & Manufacturing > Manufacturing > Products
Technology for API Solubility
| By Laboratoria Smeets
Water solubility is a big challenge for some medicines. In many cases water solubility is related to bioavailability and hence the effectiveness of the API.
Production & Manufacturing > Manufacturing > White Papers
View all Manufacturing news or find news targeted to your interests